Hutchin Hill Capital’s Idexx Laboratories IDXX Stock Holding History

Hutchin Hill Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,800	Closed	-$291K	–	838
2017 Q2	$291K	Buy	+1,800	New	+$292K	0.01%	756
2016 Q2	–	Sell	-7,200	Closed	-$564K	–	621
2016 Q1	$564K	Buy	+7,200	New	+$518K	0.02%	510
2015 Q3	–	Sell	-32,300	Closed	-$2.07M	–	669
2015 Q2	$2.07M	Buy	32,300 +20,700	+178%	+$1.43M	0.05%	314
2015 Q1	$896K	Buy	+11,600	New	+$903K	0.02%	459
2014 Q4	–	Sell	-123,200	Closed	-$7.26M	–	618
2014 Q3	$7.26M	Buy	+123,200	New	+$7.79M	0.27%	66
2014 Q2	–	Sell	-6,600	Closed	-$401K	–	664
2014 Q1	$401K	Buy	+6,600	New	+$393K	0.02%	496

Other funds holding IDXX

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Hutchin Hill Capital's IDXX Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Idexx Laboratories (IDXX) in Q3 2017, closing a stake of 1,800 shares — an estimated $291K sold.

Hutchin Hill Capital first reported a position in IDXX in Q1 2014 and held it in 6 quarters. The position peaked at $7.26M in Q3 2014. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

Hutchin Hill Capital reported no remaining Idexx Laboratories position as of Q3 2017 after selling out during the quarter.
Hutchin Hill Capital sold 1,800 Idexx Laboratories shares in Q3 2017, an estimated $291K.
Hutchin Hill Capital first reported a position in Idexx Laboratories in Q1 2014 and held it in 6 quarters.
Hutchin Hill Capital's Idexx Laboratories position peaked at $7.26M in Q3 2014.
573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.